Fresenius Medical Care participates in three-way merger to create premier value-based kidney care provider in the U.S.
The Biden Administration’s Investment in Pandemic Preparedness and Biodefense in the FY 2023 President’s Budget
Diversified Medical Healthcare Acquires Utah Lab, Dynasty Medical Laboratory Services
Renalytix Reaches Enrollment Milestone for Building KidneyIntelX as Premier Precision Medicine Platform for Kidney Disease and Diabetes
Confirmation of Appointment of Timothy Scannell to Renalytix Board of Directors
SALT LAKE CITY, March 30, 2022 /PRNewswire/ — PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today provided a business update and reported financial results for the twelve-month period ended December 31, 2021. Recent Business and Financial Updates In the first quarter of 2022, PolarityTE received approval from the U.S. […]
The total capital represents the largest seed financing for life science startups in Utah’s history
Halia Therapeutics presented data today on its NLRP3 inhibitor program at today’s 10th Annual Neurodegenerative Drug Development Summit.
Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2022
The FDA and representatives from the medical device industry have reached an agreement on proposed recommendations for MDUFA V. On March 22, FDA sent the commitment letter to Congress. Under the new agreement, the FDA would be authorized to collect at least $1.78 billion in user fees over five years. FDA could receive additional funding […]
Pfizer’s $6.7 billion bet on Arena Pharmaceuticals has delivered a phase 3 success.
Recursion reported business updates and financial results for its fourth quarter and fiscal year ending December 31, 2021.
FierceBiotech Special Report: The top 10 biotech IPOs of 2021
Achieved Record Full Year Revenue of $97.9 Million; Strength in Sales Momentum Provides Foundation to Achieve Solid FY’22
WTC UTAH HAS A RECORD $1M+ TO ADMINISTER TO UTAH SMALL BUSINESSES. Learn from World Trade Center Utah, Meridian Finance Group, and the U.S. Small Business Administration (SBA) about export programs through the Export-Import Bank of the United States (EXIM) and how State Trade Expansion Program (STEP) funds can be used for those programs as a new eligible expense.
Co-Diagnostics, Inc. Makes Strategic Additions to Scientific Advisory Board
Myriad to establish new Walter Gilbert Research and Innovation Center Company also cited among 2022 Top Workplaces USA National List by Energage
BRACAnalysis CDx is now the only germline test approved by FDA as a companion diagnostic for treatment of HER2 negative high-risk early-stage breast cancer
Company launches Precise™ Tumor test, part of a comprehensive suite combining germline, tumor and companion diagnostics in one easy-to-access solution
Acquisition offers new, differentiated, and potentially best-in-class approach to address needs of a broader number of patients with immuno-inflammatory diseases
PolarityTE Announces $5.0 Million Registered Direct Offering
The Senate HELP Committee on Tuesday voted 20-2 to advance legislation, the PREVENTS Pandemic Act.
Co-Diagnostics announced that its Board of Directors has authorized a share repurchase program that would allow the Company to repurchase up to $30 million of CODX common stock.
Legislation would combat corrupt Chinese Courts from issuing “anti-suit injunctions” that prevent companies from challenging patent infringement from Chinese companies in American courts.
The 2022 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit presented by BioUtah, BioHive and the PIVOT Center attracted a record setting 300+ registrants along with an impressive line-up of distinguished speakers, national and local investors and numerous Utah life sciences startups. Now in its 7th year, the Summit (our first in person since COVID-19) […]
Xenter has leased 30,000 square feet to accommodate explosive growth in the new Irvine Office Park in Draper, Utah.
myIntelX will be launching in conjunction with KidneyIntelX going live at Atrium Health, and will expand testing services across all Renalytix healthcare provider partners
IONIQ Sciences announced that it has acquired from OT Acceptance, LLC certain intellectual property formerly licensed to the Company by OT Acceptance.
Innovative Embolic Device by Fluidx Medical Used Successfully in a Variety of Complex Cancer Cases
Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer
Halia Therapeutics New Leadership Team
BD Names William ‘Bill’ Brown to Board of Directors
